SCHEMBL4954467

SCHEMBL4954467

CCc1c(C(=O)O)ccnc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
KDM5A P29375 6/20 0.41
KDM4C Q9H3R0 5/20 0.41
KDM4E B2RXH2 4/20 0.41
ASPH Q12797 3/20 0.41
KDM8 Q8N371 3/20 0.41
KDM5B Q9UGL1 6/20 0.40
MRGPRX4 Q96LA9 1/20 0.38
GABRP O00591 2/20 0.38
GABRD O14764 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB1 P18505 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
GABRB2 P47870 2/20 0.38
GABRA4 P48169 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1577580 0.83 KDM5B (0.46) LMNASMN1; SMN2KDM5AKDM4CKDM4E
SCHEMBL19305015 0.82 SMN1; SMN2 (0.50) LMNASMN1; SMN2KDM5AKDM4CKDM4E
SCHEMBL15351593 0.81 ATR (0.51) LMNASMN1; SMN2KDM4EL3MBTL1
SCHEMBL19857473 0.80 KDM4E (0.55) KDM5AKDM4CKDM4EASPHKDM8
SCHEMBL15527710 0.80 GABRP (0.46) LMNAKDM5AKDM4CKDM4EASPH
SCHEMBL14836840 0.79 GABRP (0.39) LMNASMN1; SMN2KDM5AKDM4CKDM4E
SCHEMBL28260878 0.79 KDM4E (0.39) LMNASMN1; SMN2KDM5AKDM4CKDM4E
SCHEMBL6931488 0.79 NOS2 (0.55) LMNAKDM5AKDM4CKDM4EASPH
SCHEMBL4762946 0.79 NAPRT (0.50) LMNAKDM5AKDM4CKDM4EASPH
SCHEMBL31402348 0.79 KDM5B (0.41) LMNASMN1; SMN2KDM5AKDM4CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119110800-A Modulators of interferon gene stimulating factor (STING), compositions and methods 健道生物医药有限公司 2024-12-10 CN disclosed
WO-2021262596-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION PMV PHARMACEUTICALS, INC. (US) 2021-12-30 WO disclosed
WO-2021007477-A1 INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS E-SCAPE BIO, INC. (US) 2021-01-14 WO disclosed
EP-1691610-B1 METHOD FOR MODIFYING THE BEHAVIOUR OF THRIPS WITH PYRIDINE DERIVATIVES NZ INST PLANT & FOOD RES LTD (NZ) 2016-03-09 EP disclosed
US-8962003-B2 Insect behaviour modifying compounds THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) 2015-02-24 US disclosed
US-20080241205-A1 Insect Behaviour Modifying Compounds THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) 2008-10-02 US disclosed
EP-1691610-A1 INSECT BEHAVIOUR MODIFYING COMPOUNDS New Zealand Institute for Crop & Food Research Limited and Plant Research International B.V. (NL) 2006-08-23 EP disclosed
WO-2005046330-A1 INSECT BEHAVIOUR MODIFYING COMPOUNDS NEW ZEALAND INSTITUTE FOR CROP & FOOD RESEARCH LIMITED (NZ) 2005-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241205-A1 Insect Behaviour Modifying Compounds PNMT, ACHE, THOP1 LMNA 4727/4885SMN1; SMN2 3673/4885KDM5A 762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.